pyropheophorbide a has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Z; Hong, W; Huang, M; Li, J; Lin, H; Liu, G; Liu, J; Liu, Y; Song, M; Wu, Z; Xu, P; Xue, J | 1 |
| Gong, Q; Gu, Z; Li, F; Li, Z; Luo, K; Pan, D; Wang, W; Wu, Y; Zhang, H; Zhang, Q; Zhang, X; Zheng, X | 1 |
2 other study(ies) available for pyropheophorbide a and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Using porphyrins as albumin-binding molecules to enhance antitumor efficacies and reduce systemic toxicities of antimicrobial peptides.
Topics: Albumins; Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Chlorophyll; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Pore Forming Cytotoxic Proteins; Porphyrins; Tumor Cells, Cultured | 2021 |
Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Chlorophyll; Female; Heparin; Lasers; Light; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoconjugates; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Reactive Oxygen Species; Spheroids, Cellular; Treatment Outcome; Tumor Burden; Tumor Microenvironment | 2021 |